The lawsuit against Medtronic alleged the company improperly induced physicians to recommend Medtronic devices to treat cardiac rhythmic disease.
The lawsuit was originally filed under the qui tam, or whistle-blower, provision of the False Claims Act.
Medtronic has agreed to pay the settling states a combined $362,362, which will be distributed to those states’ Medicaid programs.
More articles on healthcare industry lawsuits:
Detroit area physician admits providing medically unnecessary chemotherapy as part of $225M fraud scheme
Gilead Sciences faces False Claims Act case alleging defective-drug fraud
7 recent healthcare industry lawsuits, settlements
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.